CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/healthcare

healthcare organization

Hospital Universitario Araba

ES

OPENALEX: I4210108873↗ROR: 01zc1f144↗

People

Connected researchers

A. García-AlocénExact authorship link Ana González‐PintoORCID 0000-0002-2568-5179 Felipe AizpuruORCID 0000-0003-1730-6455 Itxaso González-OrtegaORCID 0000-0001-7074-4353 PATRICIA VEGA PEREZORCID 0000-0001-5377-0701 Sara BarbeitoORCID 0000-0002-8454-3947 Susana AlberichORCID 0000-0002-4945-3428

Public evidence

4 connected articles

A Systematic Review of the Molecular and Cellular Alterations Induced by Cannabis That May Serve as Risk Factors for Bipolar Disorder.2024 · Europe PMC Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial.2022 · PubMed Central Open Access Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial.2016 · PubMed Central Open Access Subclinical Depressive Symptoms and Continued Cannabis Use: Predictors of Negative Outcomes in First Episode Psychosis2015 · PubMed Central Open Access

Registered research

Connected studies

COGNITIVE BEHAVIORAL THERAPY PROGRAM TO FIRST-EPISODE PSYCHOSIS PATIENTS AND CANNABIS ABUSEnct02319746

Matched by exact identifiers only. Profile data: OpenAlex.

Hospital Universitario Araba - Medical Cannabis Research Engine